[go: up one dir, main page]

PT936903E - Agente de efeito retardador - Google Patents

Agente de efeito retardador

Info

Publication number
PT936903E
PT936903E PT96931056T PT96931056T PT936903E PT 936903 E PT936903 E PT 936903E PT 96931056 T PT96931056 T PT 96931056T PT 96931056 T PT96931056 T PT 96931056T PT 936903 E PT936903 E PT 936903E
Authority
PT
Portugal
Prior art keywords
carrier material
product
water
polymer
active agent
Prior art date
Application number
PT96931056T
Other languages
English (en)
Inventor
Gunther Beisel
Original Assignee
Gunther Beisel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunther Beisel filed Critical Gunther Beisel
Publication of PT936903E publication Critical patent/PT936903E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2063Proteins, e.g. gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polishing Bodies And Polishing Tools (AREA)
  • Cosmetics (AREA)
PT96931056T 1996-09-07 1996-09-07 Agente de efeito retardador PT936903E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1996/003950 WO1998009617A1 (de) 1996-09-07 1996-09-07 Mittel mit retardwirkung

Publications (1)

Publication Number Publication Date
PT936903E true PT936903E (pt) 2004-03-31

Family

ID=8166315

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96931056T PT936903E (pt) 1996-09-07 1996-09-07 Agente de efeito retardador

Country Status (11)

Country Link
US (1) US6541031B1 (pt)
EP (1) EP0936903B1 (pt)
AT (1) ATE251450T1 (pt)
AU (1) AU745722B2 (pt)
CA (1) CA2276283C (pt)
DE (2) DE29624397U1 (pt)
DK (1) DK0936903T3 (pt)
ES (1) ES2208761T3 (pt)
NZ (1) NZ336805A (pt)
PT (1) PT936903E (pt)
WO (1) WO1998009617A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7284300A (en) * 1999-09-06 2001-04-10 Gunther Beisel Method for improving and maintaining bowel function as well as a method for the production thereof
CA2383996A1 (en) * 1999-09-06 2001-03-15 Gunther Beisel Agent for stimulating bowel function and method for producing the same
DE10016356B4 (de) * 2000-04-03 2007-06-21 Beisel, Günther Mittel mit verbesserter Retardwirkung und Verfahren zu dessen Herstellung
WO2003002168A1 (en) * 2001-06-29 2003-01-09 Cook Biotech Incorporated Porous sponge matrix medical devices and methods
US6880570B2 (en) * 2003-08-14 2005-04-19 Delphi Technologies, Inc. Vehicle actuator
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
DE102004025495A1 (de) 2004-05-21 2005-12-15 Dr. Suwelack Skin & Health Care Ag Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern
US20100291266A1 (en) * 2009-05-15 2010-11-18 Tibor Czinki Natural Sponge Food and Regimen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435110A (en) * 1966-03-21 1969-03-25 Ethicon Inc Collagen fibril matrix pharmaceuticals
DE3429038A1 (de) * 1984-08-07 1986-02-20 B. Braun Melsungen Ag, 3508 Melsungen Wirkstoff-depot
AU7991191A (en) * 1990-05-23 1991-12-10 Southwest Research Institute Filament system for delivering a medicament and method
US5603950A (en) * 1990-08-14 1997-02-18 Ratjen; Werner Agent for oral intake
DE4025912A1 (de) * 1990-08-16 1992-02-20 Werner Ratjen Mittel zur oralen einnahme
ES2227542T3 (es) * 1993-11-03 2005-04-01 Clarion Pharmaceuticals, Inc. Parche hemostatico.
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
DE4419818C2 (de) * 1994-06-07 1998-10-22 Lohmann Therapie Syst Lts Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben

Also Published As

Publication number Publication date
DK0936903T3 (da) 2004-02-09
DE29624397U1 (de) 2003-02-20
CA2276283C (en) 2009-12-22
US6541031B1 (en) 2003-04-01
AU745722B2 (en) 2002-03-28
NZ336805A (en) 2001-01-26
CA2276283A1 (en) 1998-03-12
WO1998009617A1 (de) 1998-03-12
DE59610768D1 (de) 2003-11-13
EP0936903A1 (de) 1999-08-25
EP0936903B1 (de) 2003-10-08
ES2208761T3 (es) 2004-06-16
ATE251450T1 (de) 2003-10-15
AU6988696A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
CA2335905A1 (fr) Ensemble pour la mise en contact extemporanee d'au moins deux elements et utilisation d'un tel ensemble
CA2356860A1 (en) Osmotic delivery system having space efficient piston
ATE207374T1 (de) Implantat und applikationsvorrichtung
EE03758B1 (et) Lahustuvad oksiidid bioloogiliseks kasutamiseks
KR970702078A (ko) 우수한 습윤 일체성 및 비교적 고농도의 하이드로겔-형성 흡수 중합체를 갖는 신체 유체를 위한 흡수 부재(absorbent members for body fluids having good wet integrity and relatively high concentrations of hydrogel-forming absorbent polymer)
ES2071297T3 (es) Material compuesto de un gel dispersado en una matriz de adhesivo y metodo para preparar dicho material compuesto.
GR3025333T3 (en) Cross-linking agent
DE69832050D1 (de) Implantatmaterial mit glaspartikeln
ES2058284T3 (es) Preparado capilar.
IT1230047B (it) Protesi vascolare contenente nella parete microcapsule inglobanti cellule produttrici di ormoni.
PT936903E (pt) Agente de efeito retardador
NZ331460A (en) Microencapsulated fluorinated gases for use as imaging agents
NZ332950A (en) Wound dressing with lower section adjacent to wound to promote healing of wound, and upper section being permeable to vapor and impermeable to bacteria
ATE343364T1 (de) Verwendung von festen, gasifizierten teilchen für haarbehandlungen und diese enthaltendes haarbehandlungsmittel
EP1736170A3 (en) Agent for treating allergic or hypersensitivity condition
WO1996040074A3 (en) Device for releasing aggregation-stabilized, biologically active agent
CA2280749A1 (en) Incorporating smoke-modifying agents in smoking material rods
KR950031090A (ko) 치질 치료용 약제학적 조성물
ES2065696T3 (es) Composicion farmaceutica.
NZ331469A (en) A hand dryer and a method of disinfecting and deodorising the dryer and air emitted from it
ATE232120T1 (de) Arzneimittelträger für einen pulverinhalator sowie prozess zur herstellung desselben
Fourt Introduction to the symposium adsorption from blood or tissue onto foreign surfaces division of colloid and surface chemistry, American chemical society atlantic city, New Jersey, september 12 and 13, 1968
ES2184251T3 (es) Composicion y procedimiento para la reduccion del ruido y las incrustaciones en un sistema de refrigeracion liquido.
RU95105648A (ru) Средство для лечения ран
ATE310545T1 (de) Werkstoff zur herstellung von erzeugnissen mit fibrinolytischen und/oder antibakteriellen eigenschaften